Argifin; efficient solid phase total synthesis and evalution of analogues of acyclic peptide

Bioorganic & Medicinal Chemistry
2009.0

Abstract

An effective solid phase synthesis of Argifin, providing subsequent access to effective synthesis of analogues, was developed in 13% overall yield, as well as elucidating structure-activity relationships. The novel acyclic peptide 18b, prepared from a synthetic intermediate of Argifin, was found to be 70 times more potent as an inhibitor of Serratia marcescens chitinases B than Argifin itself.

Knowledge Graph

Similar Paper

Argifin; efficient solid phase total synthesis and evalution of analogues of acyclic peptide
Bioorganic & Medicinal Chemistry 2009.0
An efficient synthesis of argifin: A natural product chitinase inhibitor with chemotherapeutic potential
Bioorganic & Medicinal Chemistry Letters 2005.0
Computer-aided rational molecular design of argifin-derivatives with increased inhibitory activity against chitinase B from Serratia marcescens
Bioorganic & Medicinal Chemistry Letters 2009.0
Creation of Customized Bioactivity within a 14-Membered Macrolide Scaffold: Design, Synthesis, and Biological Evaluation Using a Family-18 Chitinase
Journal of Medicinal Chemistry 2015.0
Argifin, a New Chitinase Inhibitor, Produced by Gliocladium sp. FTD-0668. II. Isolation, Physico-chemical Properties, and Structure Elucidation.
The Journal of Antibiotics 2000.0
Computational analysis of the binding affinities of the natural-product cyclopentapeptides argifin and argadin to chitinase B from Serratia marcescens
Bioorganic & Medicinal Chemistry 2008.0
Argyrins, Immunosuppressive Cyclic Peptides from Myxobacteria. I. Production, Isolation, Physico-chemical and Biological Properties.
The Journal of Antibiotics 2002.0
Solid-Phase Total Synthesis of Cherimolacyclopeptide E and Discovery of More Potent Analogues by Alanine Screening
Journal of Natural Products 2012.0
Structure-Based Exploration of Cyclic Dipeptide Chitinase Inhibitors
Journal of Medicinal Chemistry 2004.0
Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors
Bioorganic & Medicinal Chemistry 2010.0